Literature DB >> 7127296

Effect of thyroid status on development of spontaneous mammary tumors in primiparous C3H mice.

B K Vonderhaar, A E Greco.   

Abstract

Development of mammary tumors in primiparous C3H/HeN mice (mouse mammary tumor virus positive) in various thyroid states was followed for one year after removal of pups. Animals were either euthyroid or made hyperthyroid (by ingestion of thyroxine) or hypothyroid (by ingestion of 2-thiouracil) during involution. These manipulations resulted in significant changes in serum 3,5,3'-triiodo-L-thyronine and thyroxine levels without significant alterations in serum prolactin levels. At the end of one year postlactation, 90 to 86% of the euthyroid and hyperthyroid animals had developed mammary tumors, while the hypothyroid groups had only 70 to 72% tumor incidence. In two separate experiments, 50% tumor incidence was reached after 237 and 252 days in the hyperthyroid animals and after 242 and 252 days in the euthyroid groups. However, 50% tumor incidence in the hypothyroid groups was not reached until 290 and 287 days. The involuted mammary glands of all three groups were morphologically indistinguishable 10 weeks after removal of the pups. However, after 30 weeks, differences were seen. While glands from hyperthyroid and euthyroid animals retained a small degree of ductal branching with primitive alveoli, the glands from hypothyroid animals showed less ductal branching and were devoid of alveoli. Thus, the decrease in mammary tumor incidence in hypothyroid primiparous mice may be due to a greater degree of regression of the mammary epithelium in these animals.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7127296

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  6 in total

1.  Influence of L-thyroxine, L-triiodothyronine, thyroid stimulating hormone, or estradiol on the cell kinetics of cultured mammary cancer cells.

Authors:  Y de Launoit; R Kiss
Journal:  In Vitro Cell Dev Biol       Date:  1989-07

2.  Cultured breast cystosarcoma phylloides cells and applications to patient therapy.

Authors:  W M Lewko; R Vaghmar; J R Maleckar; S Husseini; C A Montgomery; G B Thurman; R K Oldham
Journal:  Breast Cancer Res Treat       Date:  1990-12       Impact factor: 4.872

Review 3.  Mammary gland neoplasia in long-term rodent studies.

Authors:  I H Russo; J Russo
Journal:  Environ Health Perspect       Date:  1996-09       Impact factor: 9.031

4.  Thyroid function alters during neoadjuvant chemotherapy in breast cancer patients: results from the NEOZOTAC trial (BOOG 2010-01).

Authors:  S de Groot; L G M Janssen; A Charehbili; E M Dijkgraaf; V T H B M Smit; L W Kessels; A van Bochove; H W M van Laarhoven; E Meershoek-Klein Kranenbarg; A E van Leeuwen-Stok; C J H van de Velde; H Putter; J W R Nortier; J J M van der Hoeven; H Pijl; J R Kroep
Journal:  Breast Cancer Res Treat       Date:  2015-01-04       Impact factor: 4.872

5.  Effects of age and parity on mammary gland lesions and progenitor cells in the FVB/N-RC mice.

Authors:  Ahmed Raafat; Luigi Strizzi; Karim Lashin; Erika Ginsburg; David McCurdy; David Salomon; Gilbert H Smith; Daniel Medina; Robert Callahan
Journal:  PLoS One       Date:  2012-08-30       Impact factor: 3.240

Review 6.  Growth control and differentiation in mammary epithelial cells.

Authors:  F Borellini; T Oka
Journal:  Environ Health Perspect       Date:  1989-03       Impact factor: 9.031

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.